A recent study revealed that central and peripheral GLP-1 inhibits feeding behaviors through independent gut-brain circuits (Schick et al., 2003), mesolimbic system (Heppner and Perez-Tilve, 2015)
The review authors noted that a study in mouse models showed the GLP-1 drug liraglutide (Victoza) increased the number of astrocytes
Their education in clinical dietetics, microbiology, and chemistry offers a real edge in understanding and helping patients avoid harmful medication interactions with GLP-1 drugs
Although individual responses vary, ZepBound is often selected for patients who need the most powerful available pharmacologic support or who have already tried a GLP-1 medication without achieving the desired result
I'm a gut health dietician at Oswald Digestive Clinic, where we help individuals improve and resolve their bothersome gut issues
GLP-1 treatment starts at a low dose and increases over time